For the quarter ending 2026-03-31, VYCO made $458,540 in revenue. -$142,077 in net income. Net profit margin of -30.98%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 458,540 | 416,877 | 513,792 | 496,353 |
| Cost of goods sold | 83,387 | 81,507 | 61,860 | 81,082 |
| Gross profit | 375,153 | 335,370 | 451,932 | 415,271 |
| Research and development | 0 | 0 | 0 | 4,201 |
| Depreciation and amortization | 13,980 | 14,880 | 14,880 | 14,881 |
| Selling, general and administrative | 315,365 | 357,015 | 404,967 | 345,043 |
| Total operating expenses | 329,345 | 371,895 | 419,847 | 364,125 |
| Operating income (gain) | 45,808 | -36,525 | 32,085 | 51,146 |
| Other income | - | 0* | 0 | 0 |
| Interest expense | 12,570 | 26,304.5* | 12,571 | 12,572 |
| Interest expense-Nonrelated Party | - | - | - | 12,862 |
| (gain) loss on foreign currency exchange | -4 | 450.5* | -640 | 1 |
| Total other (expense) | -25,713 | -25,854 | -27,095 | -25,433 |
| Income (loss) before provision for income taxes | 20,095 | -62,379 | 4,990 | 25,713 |
| Provision for income taxes | 0 | 0 | 0 | 0 |
| Net income (loss) from continuing operations | 20,095 | -62,379 | 4,990 | 25,713 |
| Income (loss) from discontinued operations, net of tax | 13 | -307 | -54 | -1,826 |
| Net income (loss) | 20,108 | -62,686 | 4,936 | 23,887 |
| Preferred stock dividends | 162,185 | 0 | 162,185 | 0 |
| Net loss available to common stockholders | -142,077 | -62,686 | -157,249 | 23,887 |
| Basic EPS | 0 | -0.002 | 0 | 0 |
| Diluted EPS | 0 | -0.002 | 0 | 0 |
| Basic Average Shares | 33,372,796 | 33,372,796 | 33,372,796 | 33,372,796 |
| Diluted Average Shares | 33,372,796 | 28,077,730 | 33,372,796 | 38,667,862 |
VYCOR MEDICAL INC (VYCO)
VYCOR MEDICAL INC (VYCO)